We are live on
!
Find out more
Nordea Investment Management Portfolio holdings
AUM
$123B
1-Year Est. Return
38.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
+38.85%
3 Year Est. Return
+108.43%
5 Year Est. Return
+135.66%
10 Year Est. Return
+417.19%
AUM
$39.7B
AUM Growth
+$1.89B
(+5%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
23.99%
Holding
1,116
New
80
Increased
548
Reduced
258
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$334M |
| 2 |
IBM
IBM
|
+$308M |
| 3 |
AutoZone
AZO
|
+$207M |
| 4 |
Walt Disney
DIS
|
+$191M |
| 5 |
Omnicom Group
OMC
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$215M |
| 2 |
Elevance Health
ELV
|
+$204M |
| 3 |
PG&E
PCG
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$146M |
| 5 |
American Electric Power
AEP
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.39% |
| 2 | Technology | 17.17% |
| 3 | Communication Services | 12.47% |
| 4 | Financials | 11.82% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Zoetis
ZTS
$30B
| $1.55M | ﹤0.01% |
24,854
+169
| +0.7% | +$9.98K |
|
702
Petrobras Class A
PBR.A
$103B
| $1.48M | ﹤0.01% |
197,667
+35,522
| +22% | +$301K |
|
703
MSCI
MSCI
$40.9B
| $1.47M | ﹤0.01% |
14,313
+164
| +1% | +$16.5K |
|
704
Dr. Reddy's Laboratories
RDY
$10.2B
| $1.47M | ﹤0.01% |
174,500
| – | – |
|
|
KMG
705
DELISTED
KMG Chemicals Inc
KMG
| $1.47M | ﹤0.01% |
+30,100
| New | +$1.54M |
|
706
CytomX Therapeutics
CTMX
$754M
| $1.45M | ﹤0.01% |
+93,613
| New | +$1.41M |
|
707
Archer Daniels Midland
ADM
$36.9B
| $1.37M | ﹤0.01% |
33,182
+4,342
| +15% | +$186K |
|
|
VDTH
708
DELISTED
Videocon d2h Limited
VDTH
| $1.36M | ﹤0.01% |
140,110
+44,951
| +47% | +$470K |
|
709
Air Products & Chemicals
APD
$67.6B
| $1.36M | ﹤0.01% |
9,500
+121
| +1% | +$17.2K |
|
710
Assurant
AIZ
$14.3B
| $1.35M | ﹤0.01% |
13,042
+4,022
| +45% | +$401K |
|
711
CACI
CACI
$14.2B
| $1.35M | ﹤0.01% |
10,801
-124,581
| -92% | -$15.1M |
|
|
GTS
712
DELISTED
Triple-S Management Corporation
GTS
| $1.33M | ﹤0.01% |
82,932
+525
| +0.6% | +$8.62K |
|
713
Yum! Brands
YUM
$41.1B
| $1.33M | ﹤0.01% |
18,036
| – | – |
|
714
DXC Technology
DXC
$1.73B
| $1.32M | ﹤0.01% |
+19,963
| New | +$1.32M |
|
|
RYZ
715
Ryerson Holding Corp
RYZ
$1.46B
| $1.31M | ﹤0.01% |
132,600
+1,100
| +0.8% | +$11.7K |
|
|
PXD
716
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.28M | ﹤0.01% |
8,003
+41
| +0.5% | +$7.01K |
|
|
AXAS
717
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.24M | ﹤0.01% |
38,395
-2,050
| -5% | -$77K |
|
718
Williams Companies
WMB
$86.1B
| $1.22M | ﹤0.01% |
40,300
+584
| +1% | +$17.4K |
|
719
Edwards Lifesciences
EW
$51.7B
| $1.2M | ﹤0.01% |
30,375
| – | – |
|
720
Sempra
SRE
$54.8B
| $1.2M | ﹤0.01% |
21,216
+180
| +0.9% | +$10.2K |
|
721
Quest Diagnostics
DGX
$26.3B
| $1.19M | ﹤0.01% |
10,722
-232
| -2% | -$24.5K |
|
722
F5
FFIV
$22.7B
| $1.18M | ﹤0.01% |
9,303
+196
| +2% | +$25.7K |
|
723
Illumina
ILMN
$28.4B
| $1.18M | ﹤0.01% |
6,988
+43
| +0.6% | +$7.44K |
|
724
TSMC
TSM
$2.18T
| $1.16M | ﹤0.01% |
33,099
-2,533
| -7% | -$87.6K |
|
|
LOGM
725
DELISTED
LogMein, Inc.
LOGM
| $1.16M | ﹤0.01% |
11,064
-85
| -0.8% | -$9.3K |
|
Similar funds
VAM
Nordea Investment Management's Q2 2017 Portfolio in Review
As of Q2 2017, Nordea Investment Management held 1,116 positions worth $39.7B, up 5% from $37.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Nordea Investment Management's Q2 2017 filing shows 80 new, 548 increased, 258 reduced and 68 closed positions. Its largest new stake was Buckeye Partners, L.P.: 851,332 shares worth $54.4M. The largest sale was Johnson & Johnson, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.
- Nordea Investment Management's largest Q2 2017 buy was Buckeye Partners, L.P.: 851,332 shares worth $54.4M.
- Nordea Investment Management added most to Merck in Q2 2017, an estimated $334M increase.
- Nordea Investment Management's biggest Q2 2017 reduction was Johnson & Johnson, cutting an estimated $215M.
- Nordea Investment Management fully exited L3Harris in Q2 2017, selling an estimated $34.4M.
- Nordea Investment Management's ten largest holdings make up 24% of its $39.7B portfolio in Q2 2017.
- Nordea Investment Management opened 80 new positions and closed 68 in Q2 2017.
- Nordea Investment Management's portfolio value rose 5% quarter-over-quarter to $39.7B.
Based on Nordea Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.